Study With Two Coenzyme Q10 Products

Last updated: December 4, 2025
Sponsor: University of Primorska
Overall Status: Completed

Phase

N/A

Condition

N/A

Treatment

Dietary supplement - Experimental product

Dietary supplement - Active comparator

Clinical Study ID

NCT06736366
Q10_2024
  • Ages 50-65
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The randomized, open-label, two period crossover single-dose bioavailability study with two coenzyme Q10 products

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • subject informed consent form

  • aged between 50 and 65 years old

  • body mass for women 70± 5 kg and for men 85± 5 kg

  • non-smoking

  • healthy, without cardio-vascular diseases, diabetes, neurodegenerative diseases

  • absence of any prescribed medication during the study

  • willing to avoid a consumption of any food supplements at least 2 weeks before andduring the study

Exclusion

Exclusion Criteria:

  • cardio-vascular diseases, diabetes, neurodegenerative diseases, gastrointestinaldisorders, pregnancy, breast-feeding

  • intake of any food supplements within two week of the beginning of the study

  • drug or alcohol abuse

Study Design

Total Participants: 25
Treatment Group(s): 2
Primary Treatment: Dietary supplement - Experimental product
Phase:
Study Start date:
December 05, 2024
Estimated Completion Date:
June 30, 2025

Study Description

The randomized, open-label, two period crossover single-dose bioavailability study with two coenzyme Q10 products will include 35 subjects who will test two different coenzyme Q10 products. Plasma concentration of coenzyme Q10 will be measured.

Connect with a study center

  • University of Primorska, Faculty of Health Sciences

    Izola 3199017, Izola 3199016 6310
    Slovenia

    Site Not Available

  • University of Primorska, Faculty of Health Sciences

    Izola, 6310
    Slovenia

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.